Company Filing History:
Years Active: 2012
Title: Myles Limbrick: Innovator in Medication Delivery Systems
Introduction
Myles Limbrick is a notable inventor based in London, Canada. He has made significant contributions to the field of medication delivery systems, particularly focusing on improving the efficacy of treatments for children and infants.
Latest Patents
Myles Limbrick holds a patent for "Systems and methods for evaluating medication delivery from valved holding chambers with a facemask using a model face." This innovative patent describes a model face that includes a base, an elastomer cast, an air pocket, and a mouth opening. The elastomer cast simulates the soft tissues of a child's face, allowing for accurate evaluation of medication delivery through valved holding chambers (VHCs). This invention is crucial for ensuring that medications are effectively delivered to young patients.
Career Highlights
Myles Limbrick is currently employed at Trudell Medical International, where he continues to develop and refine medical technologies. His work focuses on enhancing the delivery of medications to pediatric patients, ensuring that treatments are both effective and safe.
Collaborations
Myles collaborates with talented professionals in his field, including Robert Morton and Mark Nagel. Their combined expertise contributes to the advancement of innovative medical solutions.
Conclusion
Myles Limbrick's work in medication delivery systems exemplifies the importance of innovation in healthcare. His patent and ongoing contributions are paving the way for improved treatment options for children and infants.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.